National Registry for Patients with Parkinsonian Disorders in China

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to create a comprehensive registry for individuals with Parkinsonian disorders in China, utilizing a mobile application called PaWei for data collection. Participants will provide demographic information, health history, and undergo various assessments through self-reported online questionnaires. The study will monitor participants longitudinally, collecting data every three months to better understand the condition and its impact on patients' lives. The registry will facilitate communication between patients, doctors, and researchers, enhancing the understanding of Parkinsonian disorders.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Anyone with Parkinsonian Disorders is welcome to join the Registry.

Exclusion Criteria:

Where it's running

• Huashan Hospital Affiliated to Fudan University
  Shanghai, Shanghai Municipality, China Recruiting
• Huashan Hospital
  Shanghai, Shanghai Municipality, China Recruiting

Study contacts

• Study coordinator: Jian Wang, MD
• Email: wangjian336@hotmail.com
• Phone: 86-21-52888160

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Increasing daily physical activity to slow cognitive decline in alpha-synuclein disorders

  This study will test whether using a motivational smartphone app to increase everyday physical activity can help slow cognitive decline in people aged 50–80 with isolated REM sleep behavior disorder (an early sign of alpha‑synuclein disease).

  Recruiting University Hospital, Bonn · Bonn, North Rhine West-Falia · NCT07324330

• Axial and cognitive symptoms and biomarkers in brain‑first versus body‑first Parkinson's disease

  This project will test whether clinical exams, sleep testing, heart and brain scans, and blood/CSF biomarkers can distinguish brain‑first from body‑first early Parkinson's patients and predict worsening of balance and thinking problems.

  Recruiting Azienda USL Reggio Emilia - IRCCS · Reggio Emilia · NCT07187843

• Slow-SPEED: Can a smartphone app help people with prodromal Parkinson's stay more active?

  This trial tests whether a remote smartphone app can help people with a LRRK2 G2019S or GBA1 N370S mutation increase daily activity and see if exercise might slow prodromal Parkinson's signs.

  Recruiting Radboud University Medical Center · Rochester, New York and 1 other locations · NCT06993142

• Increasing physical activity in patients at risk of Parkinson's disease using a smartphone app

  This study is testing a smartphone app to help people at risk of Parkinson's disease increase their physical activity and exercise intensity over two years.

  Recruiting Radboud University Medical Center · Nijmegen, Gelderland · NCT06193252

• Single NouvNeu001 (dopaminergic progenitor cells) injection for MSA-P

  This Phase I trial will test whether a single injection of NouvNeu001 (human dopaminergic progenitor cells) is safe and may help people aged 30–70 with early Multiple System Atrophy, Parkinsonian subtype.

  Recruiting Phase 1 iRegene Therapeutics Co., Ltd. · Beijing, Beijing Municipality · NCT07289477

• Epidural electrical stimulation to manage low blood pressure in Parkinson's disease

  This study will try epidural electrical stimulation (ARC-IM) to see if it helps people with typical or atypical Parkinson's disease who have symptomatic orthostatic hypotension.

  Recruiting Ecole Polytechnique Fédérale de Lausanne · Lausanne, Canton of Vaud · NCT06920134

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.